United States · FDA National Drug Code directory
GUAIFENESIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82804-265_28b31f37-6896-40f5-8f3a-60c93c5c1278
- Product NDC
- 82804-265
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- GUAIFENESIN
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220819
- Source listing expiry
- 20271231
Source-listed ingredients
- GUAIFENESIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (82804-265-20) · 82804-265-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →